Lifestyle Intervention Modulates the CD4+ T Cell Profile in the Blood of Crohn's Disease Patients.

Alexandra Mekes-AdamczykNadine GausmannÖzlem ÖznurKatrin PfuhlmannJan DziobakaJan BuerJost LanghorstAstrid M Westendorf

Published in: Inflammatory bowel diseases (2024)

The MBM program, whether guided or self-directed, has the potential to restore the CD4+ T cell profile of CD patients to levels comparable to healthy blood donors. Lifestyle interventions may benefit CD progression, symptoms, and immunological status, but further analysis is needed to substantiate these findings and to fully understand their clinical implications. (ClinicalTrials.gov: NCT05182645).

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
physical activity
randomized controlled trial
cardiovascular disease
metabolic syndrome
peritoneal dialysis
type diabetes
climate change